Trial Profile
Evaluation of the Sensory Attributes of Olapatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2010
Price :
$35
*
At a glance
- Drugs Olopatadine (Primary) ; Azelastine
- Indications Allergic rhinitis
- Focus Pharmacodynamics
- Sponsors Alcon
- 09 Nov 2008 New trial record.